DE3064453D1 - Isoquinoline acetic acids and pharmaceutical compositions thereof - Google Patents

Isoquinoline acetic acids and pharmaceutical compositions thereof

Info

Publication number
DE3064453D1
DE3064453D1 DE8080304517T DE3064453T DE3064453D1 DE 3064453 D1 DE3064453 D1 DE 3064453D1 DE 8080304517 T DE8080304517 T DE 8080304517T DE 3064453 T DE3064453 T DE 3064453T DE 3064453 D1 DE3064453 D1 DE 3064453D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
acetic acids
isoquinoline acetic
isoquinoline
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080304517T
Other languages
German (de)
English (en)
Inventor
Rodney Caughren Schnur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of DE3064453D1 publication Critical patent/DE3064453D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DE8080304517T 1979-12-18 1980-12-15 Isoquinoline acetic acids and pharmaceutical compositions thereof Expired DE3064453D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/104,939 US4283539A (en) 1979-12-18 1979-12-18 Isoquinoline acetic acids

Publications (1)

Publication Number Publication Date
DE3064453D1 true DE3064453D1 (en) 1983-09-01

Family

ID=22303241

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080304517T Expired DE3064453D1 (en) 1979-12-18 1980-12-15 Isoquinoline acetic acids and pharmaceutical compositions thereof

Country Status (7)

Country Link
US (1) US4283539A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0030861B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5692871A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3064453D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK149569C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR72804B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE50524B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761403A (en) * 1986-04-09 1988-08-02 Abbott Laboratories Lipoxygenase inhibiting compounds
AU3921395A (en) * 1994-12-06 1996-06-26 Sig Schweizerische Industrie-Gesellschaft Transverse sealing device for tubular bag forming, filling and sealing machines
GB9424842D0 (en) * 1994-12-09 1995-02-08 British Tech Group Pharmaceutical compositions
ATE404539T1 (de) 1997-10-02 2008-08-15 Eisai R&D Man Co Ltd Kondensierte pyridinderivate
AU774929B2 (en) * 1998-03-31 2004-07-15 Institutes For Pharmaceutical Discovery, Llc, The Substituted indolealkanoic acids
TNSN99224A1 (fr) * 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
US7151102B2 (en) 2000-10-30 2006-12-19 Kudos Pharmaceuticals Limited Phthalazinone derivatives
CA2444531A1 (en) 2001-05-08 2002-11-14 Kudos Pharmaceuticals Limited Isoquinolinone derivatives as parp inhibitors
EP1501822B1 (en) 2002-04-30 2010-12-15 Kudos Pharmaceuticals Limited Phthalazinone derivatives
JP2006500336A (ja) * 2002-07-26 2006-01-05 ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー 糖尿病合併症の処置に使用するための置換インドールアルカン酸誘導体及びそれを含む製剤。
AU2003289386A1 (en) * 2002-12-18 2004-07-09 Takeda Pharmaceutical Company Limited Jnk inhibitors
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0419072D0 (en) 2004-08-26 2004-09-29 Kudos Pharm Ltd Phthalazinone derivatives
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
EP2188278A1 (en) 2007-09-14 2010-05-26 AstraZeneca AB Phthalazinone derivatives
BRPI0817537B1 (pt) 2007-10-17 2022-04-05 Kudos Pharmaceuticals Limited 4-[3-(4-ciclopropanocarbonil-piperazina-1-carbonil)-4-fluoro-benzil]-2h-ftalazin-1-ona, método para obtê-lo, composição farmacêutica compreendendo o mesmo, bem como usos terapêuticos do dito composto
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
AU2009300866B2 (en) 2008-10-07 2013-03-28 Kudos Pharmaceuticals Limited Pharmaceutical formulation 514
WO2011162274A1 (ja) * 2010-06-23 2011-12-29 大正製薬株式会社 イソキノリン誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4036964A (en) * 1973-10-11 1977-07-19 Beecham Group Limited Isocarbostyril-3-carboxylic acid derivatives for the prophylaxis of asthma, hayfever and rhinitis

Also Published As

Publication number Publication date
EP0030861B1 (en) 1983-07-27
DK149569C (da) 1987-02-02
JPS5692871A (en) 1981-07-27
EP0030861A3 (en) 1981-09-23
US4283539A (en) 1981-08-11
DK536480A (da) 1981-06-19
JPS6210508B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-03-06
GR72804B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-12-05
DK149569B (da) 1986-07-28
IE50524B1 (en) 1986-04-30
IE802661L (en) 1981-06-18
EP0030861A2 (en) 1981-06-24

Similar Documents

Publication Publication Date Title
IL59628A (en) 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them
DE3064453D1 (en) Isoquinoline acetic acids and pharmaceutical compositions thereof
IL60095A0 (en) Pharmaceutical compositions comprising nalbuphine and acetaminophen
GB2103591B (en) Pharmaceutical compositions and process
NZ218192A (en) Heterocyclic oxophthalazinyl acetic acids and pharmaceutical compositions
NZ189296A (en) N-substituted-omega-aminoalkanoyl-omega-aminoalkanoic acids and pharmaceutical compositions
PH21906A (en) Quinoline carboxylic acids and pharmaceutical composition containing the same
NZ190842A (en) 4-substituted-thiazole-2-oxamic acids and esters and pharmaceutical compositions
IL58656A0 (en) Halogen substituted benzopyran-and benzothiopyran-4-carboxylic acids and pharmaceutical compositions containing them
ZA822933B (en) Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation
NZ195415A (en) Oxocarboxylic acids and medicaments
NZ192207A (en) Amino-thiazolacetamido-3-cephem-4-carboxylic acids pharmaceutical compositions and thiazole intermediates
IL54200A0 (en) The preparation of dihalogenovinylcyclopropanecarboxylic acids and their esters
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
IL61179A0 (en) 2-amino-4-substituted-5-thiazolecarboxylic acids and their derivatives
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
GB2057427B (en) Oxoimidazolinealkanoic acids and their salts and esters their preparation and pharmaceutical compositions containing them
NZ194241A (en) 7b-aminothiadiazolylacetamido-3-cephem-4 carboxylic acid derivatives and pharmaceutical compositions
IL64713A0 (en) Preparation of 2,2-dimethyl-3-vinylcyclopropanecarboxylic acids and esters thereof
NZ190245A (en) Isoquinoline derivatives and pharmaceutical compositions containing them
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
DE3064472D1 (en) Preparation of acids and esters
NZ189295A (en) N-substituted-acyl-aminoalkanoic acids and pharmaceutical compositions
IL58438A0 (en) Isoquinoline derivatives their preparation and pharmaceutical compositions containing them
NZ187474A (en) 4-heterocyclyl-piperazine-i-carbodithioic acids and salts and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee